Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Angio-Oedema and/or Urticaria”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Testing effectiveness (Phase 2)Ended earlyNCT05055258
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of Different Doses of KVD824 for Prophylactic Treatment of HAE Type I or II

Who this might be right for
Angioedema, Hereditary, Types I and II
KalVista Pharmaceuticals, Ltd. 33
Testing effectiveness (Phase 2)Ended earlyNCT05047185
What this trial is testing

Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II

Who this might be right for
Hereditary AngioedemaHereditary Angioedema Type IHereditary Angioedema Type II+7 more
Pharvaris Netherlands B.V. 34
Large-scale testing (Phase 3)Ended earlyNCT01275976
What this trial is testing

Effect of C1-esterase Inhibitor on Systemic Inflammation in Trauma Patients With a Femur or Pelvic Fracture

Who this might be right for
TraumaInflammationSepsis+1 more
UMC Utrecht 11
Testing effectiveness (Phase 2)Study completedNCT04208412
What this trial is testing

A Phase II, Cross-over Clinical Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) in the On-demand Treatment of Angioedema Attacks in Adult Subjects With Hereditary Angioedema Type I or II

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 84
Not applicableUnknownNCT00163839
What this trial is testing

The Efficacy of a Pseudoallergen-Free Diet in the Treatment of Chronic Idiopathic Urticaria and/or Angioedema

Who this might be right for
UrticariaAngioedema
Bayside Health 50
Not applicableStudy completedNCT01541423
What this trial is testing

A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire 83
Large-scale testing (Phase 3)Active Not RecruitingNCT06634420
What this trial is testing

HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema
Intellia Therapeutics 80
Large-scale testing (Phase 3)Study completedNCT00125151
What this trial is testing

C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema

Who this might be right for
Angioedema
Prothya Biosolutions 15
Large-scale testing (Phase 3)Study completedNCT05505916
What this trial is testing

An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 145
Not applicableStudy completedNCT03240991
What this trial is testing

Study of Clinical, Biological Characteristics and Quality of Life of Patients With Hereditary or Acquired Non Drug-induced Bradykinin-mediated Angioedema, Monitored in Besançon's Partner Site Reference Center for Studies of Kinin-mediated Angioedema (CREAK)

Who this might be right for
Angioedema
Centre Hospitalier Universitaire de Besancon 45
Large-scale testing (Phase 3)Study completedNCT00125541
What this trial is testing

C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema

Who this might be right for
Angioedema
Prothya Biosolutions 6
Large-scale testing (Phase 3)Study completedNCT05139810
What this trial is testing

OASIS-HAE: A Study to Evaluate the Safety and Efficacy of Donidalorsen (ISIS 721744 or IONIS-PKK-LRx) in Participants With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema
Ionis Pharmaceuticals, Inc. 91
Not applicableNot Yet RecruitingNCT07218393
What this trial is testing

A Study About the Diagnosis and Management of Hereditary Angioedema (HAE) in Egypt

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 100
Not applicableLooking for participantsNCT07359430
What this trial is testing

Deep Phenotyping of CIndU

Who this might be right for
Skin DiseasesAngio-Oedema and/or Urticaria
Centre for Human Drug Research, Netherlands 40
Large-scale testing (Phase 3)Study completedNCT05511922
What this trial is testing

PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 11
Not applicableApproved For MarketingNCT06628713
What this trial is testing

Treatment of Angioedema Attacks in Adolescent and Adult Patients 12 Years and Older With HAE Type I or II With Sebetralstat

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd.
Not applicableStudy completedNCT04861090
What this trial is testing

A Study in Teenagers and Adults With Hereditary Angioedema (HAE) Type I or Type II Who Use Lanadelumab as Long-Term Prophylaxis

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 207
Large-scale testing (Phase 3)Study completedNCT06467084
What this trial is testing

Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 36
Large-scale testing (Phase 3)Study completedNCT05259917
What this trial is testing

A Phase III, Crossover Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 136
Not applicableStudy completedNCT04130191
What this trial is testing

Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II

Who this might be right for
Hereditary Angioedema (HAE)
Shire 140
Next Page